wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34894883-5439314E-075C-41E7-9B57-BAC577F19529
Q34894883-5439314E-075C-41E7-9B57-BAC577F19529
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34894883-5439314E-075C-41E7-9B57-BAC577F19529
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.
P2860
Q34894883-5439314E-075C-41E7-9B57-BAC577F19529
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34894883-5439314E-075C-41E7-9B57-BAC577F19529
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cf8faeb5d91be852bc7ea4ffe791ef824ec6f00
P2860
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.